34 filings
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
6 May 24
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
4:04pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
20 Mar 24
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
4:05pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
5 Feb 24
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of
8:10am
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
19 Dec 23
Departure of Directors or Certain Officers
4:06pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
14 Dec 23
Other Events
8:05am
8-K
73i1sy7 7b0o
8 Nov 23
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
4:10pm
8-K
pckhfm jqwqekgn
1 Nov 23
Entry into a Material Definitive Agreement
4:04pm
8-K
0m731mi
25 Oct 23
Other Events
8:03am
8-K
37g2jiyfoh800t0
7 Sep 23
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
5:04pm
8-K
jwf7dqympcam wpn6sm
11 Aug 23
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
4:05pm
8-K
9h4a9
5 Jun 23
Entry into a Material Definitive Agreement
8:00am
8-K
h6h0n83
30 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
zurr17ml85 mi45m0of
10 May 23
Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update
4:16pm
8-K
f7u7yrhw07ponzg0 kua
5 Apr 23
Other Events
4:10pm
8-K
hxvb0eqj
22 Mar 23
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
4:04pm
8-K
res61 7aue1fwb
9 Jan 23
Entry into a Material Definitive Agreement
8:09am
8-K
czgev9 z3
5 Jan 23
Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update
4:19pm
8-K
9of1d0 k19bi7syl
30 Dec 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
11:57am
8-K
iule 2wtd
6 Dec 22
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
4:05pm
8-K
lkg9c
10 Nov 22
Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:01pm